The Patent Finder

Terms ending in 2037

Helio LLC

Every in-force patent on Helio LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,829,821Leukemia Methylation Markers and Uses Thereof
In force
 · High confidence
Helio Health Inc.In forceHigh confidence
US 10,544,467Solid Tumor Methylation Markers and Uses Thereof
In force
 · Medium confidence
Helio Health Inc.In forceMedium confidence
US 12,351,876Colon Cancer Methylation Markers and Uses Thereof
In force
 · High confidence
Helio Health Inc.In forceHigh confidence
US 12,359,258Lung Cancer Methylation Markers and Uses Thereof
In force
 · High confidence
Helio Health Inc.In forceHigh confidence
US 12,359,257Liver Cancer Methylation Markers and Uses Thereof
In force
 · Medium confidence
Helio Health Inc.In forceMedium confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited